It was reported that ABCG1 could reduce the synthesis of Aβ peptides by enhancing cholesterol efflux from neurons to apolipoprotein E, and might play an additional proposed role in restricting the brain entry of Aβ in AD (Sano et al., 2016; Dodacki et al., 2017). This evidence concerns the gene ABCG1 and Alzheimer disease.